PROB.ST Stock - Probi AB (publ)
Unlock GoAI Insights for PROB.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $627.69M | $618.28M | $658.18M | $717.16M | $626.19M |
| Gross Profit | $220.21M | $255.44M | $288.01M | $309.96M | $291.65M |
| Gross Margin | 35.1% | 41.3% | 43.8% | 43.2% | 46.6% |
| Operating Income | $11.32M | $50.57M | $109.24M | $123.68M | $111.54M |
| Net Income | $16.82M | $40.62M | $83.14M | $92.69M | $85.89M |
| Net Margin | 2.7% | 6.6% | 12.6% | 12.9% | 13.7% |
| EPS | $1.48 | $3.57 | $7.30 | $8.14 | $7.54 |
Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.
Visit WebsiteEarnings History & Surprises
PROB.STEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 20, 2025 | — | — | — | — |
Q3 2025 | Jul 14, 2025 | — | — | — | — |
Q2 2025 | Apr 21, 2025 | — | — | — | — |
Q1 2025 | Feb 28, 2025 | — | — | — | — |
Q4 2024 | Oct 22, 2024 | — | $0.31 | — | — |
Q3 2024 | Jul 16, 2024 | — | $0.71 | — | — |
Q2 2024 | Apr 23, 2024 | — | $0.16 | — | — |
Q1 2024 | Jan 26, 2024 | — | $-0.23 | — | — |
Q4 2023 | Oct 24, 2023 | — | $0.56 | — | — |
Q3 2023 | Jul 18, 2023 | — | $-0.55 | — | — |
Q2 2023 | Apr 26, 2023 | — | $1.69 | — | — |
Q1 2023 | Jan 27, 2023 | $1.89 | $-0.50 | -126.5% | ✗ MISS |
Q4 2022 | Oct 21, 2022 | $2.13 | $1.09 | -48.8% | ✗ MISS |
Q3 2022 | Jul 15, 2022 | $1.58 | $1.75 | +10.8% | ✓ BEAT |
Q2 2022 | Apr 26, 2022 | $2.31 | $1.23 | -46.8% | ✗ MISS |
Q1 2022 | Feb 2, 2022 | $2.29 | $2.31 | +0.9% | ✓ BEAT |
Q4 2021 | Oct 22, 2021 | $2.23 | $1.62 | -27.4% | ✗ MISS |
Q3 2021 | Jul 16, 2021 | $2.43 | $1.39 | -42.8% | ✗ MISS |
Q2 2021 | Apr 23, 2021 | $2.04 | $1.99 | -2.5% | ✗ MISS |
Q1 2021 | Feb 9, 2021 | $2.43 | $1.92 | -21.0% | ✗ MISS |
Latest News
Frequently Asked Questions about PROB.ST
What is PROB.ST's current stock price?
What is the analyst price target for PROB.ST?
What sector is Probi AB (publ) in?
What is PROB.ST's market cap?
Does PROB.ST pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PROB.ST for comparison